NASDAQ:ENGN | Profit Breakdown | enGene Therapeutics Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2022-10-31 to 2026-04-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-04-30-$31.97M-$30.23M-$30.23M
2026-01-31-$31.19M-$29.75M-$29.75M
2025-10-31-$39.48M-$38.38M-$37.88M
2025-07-31-$29.95M-$28.75M-$28.99M
2025-04-30-$27.12M-$25.58M-$25.82M
2025-01-31-$26.61M-$24.6M-$24.62M
2024-10-31-$17.46M-$15.28M-$15.3M
2024-07-31-$16.76M-$14.18M-$14.15M
2024-04-30-$17.31M-$14.96M-$14.98M
2024-01-31-$10.77M-$10.74M-$10.71M
2023-10-31-$10.44M-$82.48M-$82.5M
2023-07-31-$6.25M-$4.72M-$4.72M
2023-04-30-$4.74M-$5.28M-$5.28M
2023-01-31-$4.63M-$7.42M-$7.42M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-10-31-$123.17M-$117.3M-$117.3M
2024-10-31-$62.3M-$55.16M-$55.14M
2023-10-31-$26.06M-$99.9M-$99.92M
2022-10-31-$19.43M-$24.44M-$24.46M